Pui CH. Recent research advances in childhood acute lymphoblastic leukemia[J]. J Formos Med Assoc, 2010, 109(11): 777-787.
[5]
Li Y, Huang S, Wang X, et al. Rituximab combined with autologous peripheral blood stem cell transplantation improve therapeutic effects of chemotherapy in pediatric patients with Burkitt's lymphoma[J]. J Trop Pediatr, 2010, 56(5): 337-341.
Dallorso S, Manzitti C, Morreale G, et al. High dose thrapy and autologous hematopoietic stem cell transplantation in poor risk solid tumors of childhood[J]. Haematologica, 2000, 85(11 Suppl): 66-70.
[8]
Raquel V, Begona S, Fernando BA, et al. Tuberculosis in pediatric solid organ and hematopoietic stem cell transplant percipients[J]. Pediatr Infect Disease J, 2012, 31(7): 774-777.
[9]
Franca F, Eleonora B, Luana M, et al. High-dose thiotepa and etoposide in Children with poor-prognosis brain tumors[J]. Cancer, 2004, 100(10): 2215-2221.
[10]
Balwierz W, Wieczorek A, Klekawka T, et al. Treatment results of children with neuroblastoma: report of Polish Pediatric Solid Tumor Group[J]. Przegl Lek, 2010, 67(6): 387-392.
[11]
施诚仁. 小儿实体肿瘤的外科治疗[J]. 儿童肿瘤, 2007, 6(2): 4-5.
[12]
Kwon SY, Won SC, Han JW, et al. Feasibility of sequential high-dose chemotherapy in advanced pediatric solid tumors[J]. Pediatr Hematol Oncol, 2010, 27(1): 1-12.
[13]
Malik PS, Bakhshi S. Renal impairment due to white-cell lysis after G-CSF and chemotherapy during pediatric autologous stem cell transplantation[J]. J Pediatr Hematol Oncol, 2010, 32(5): 416-417.
[14]
Sari T, Yuksel MK, Topcuoglu P, et al. The effect of CD34 count and clonogenic potential of hematopoietic stem cells on engraftment[J]. Transfus Apher Sci, 2010, 43(3): 315-320.
[15]
Matthay KK, Reynolds CP, Seeger RC, et al. Treatment of high-risk neuroblastoma with intensive chemptherapy, radiotherapy. Autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group[J]. N EnglJ Med, 1999, 341(16): 1165-1173.
[16]
Zhu HH, Xu KL, Huang YH, et al. Observation of clinical effect of MA or MOED regimen combined with hematopoietic growth factor on mobilization of autologous peripheral blood stem cells[J]. Leukemia Lymphoma, 2002, 11(9): 349-352.
[17]
Tsuruta T, Aihara Y, Kanno H, et al. High-dose chemotherapy followed by autologous and allogeneic peripheral blood stem cell transplantation for recurrent disseminated trilateral retinoblastoma[J]. Child Nerv Syst, 2011, 27(6): 1019-1024.
[18]
Angela P, Theodore BM, Pamela K. Efficacy of high-dose chemotherapy and atuologous stem cell transplant for recurrent Wilm's tumor: a Meta-analysis[J]. J Pediatr Hematol Oncol, 2010, 32 (6): 454-461.
